Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. drugmaker’s respiratory treatments.
Recent Posts
- Trump sends more letters dictating high tariff rates around the world
- Homeland Security corrects data error — international student enrollment rose, not declined
- Photos show Altman, Iger and Cook arrive at ‘summer camp for billionaires’ in Sun Valley
- Linda Yaccarino steps down as CEO of Elon Musk’s X
- Nvidia hits $4 trillion market cap, first company to do so